Follow this preprint

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19

Georgios Voloudakis, Kyung Min Lee, James M. Vicari, Wen Zhang, Daisy Hoagland, Sanan Venkatesh, Jiantao Bian, Marios Anyfantakis, Zhenyi Wu, Samir Rahman, Lina Gao, Kelly Cho, Jennifer S. Lee, Sudha K. Iyengar, Shiuh-Wen Luoh, Themistocles L. Assimes, Gabriel E. Hoffman, Benjamin R. tenOever, John F. Fullard, Julie A. Lynch, Panos Roussos
doi: https://doi.org/10.1101/2025.01.10.25320348
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2025.01.10.25320348
History 
  • January 14, 2025.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Georgios Voloudakis1,2,3,4,5,6,7,*,†,
  2. Kyung Min Lee8,*,
  3. James M. Vicari1,2,3,4,*,
  4. Wen Zhang1,2,3,4,
  5. Daisy Hoagland9,10,11,
  6. Sanan Venkatesh1,2,3,4,6,7,
  7. Jiantao Bian8,12,
  8. Marios Anyfantakis1,2,3,4,6,7,
  9. Zhenyi Wu1,2,3,4,6,7,
  10. Samir Rahman1,2,3,4,
  11. Lina Gao13,
  12. Kelly Cho14,15,
  13. Jennifer S. Lee16,17,
  14. Sudha K. Iyengar18,19,20,
  15. Shiuh-Wen Luoh21,22,
  16. Themistocles L. Assimes16,17,
  17. Gabriel E. Hoffman1,2,3,4,
  18. Benjamin R. tenOever9,10,11,
  19. John F. Fullard1,2,3,4,‡,
  20. Julie A. Lynch8,12,‡ and
  21. Panos Roussos1,2,3,4,6,7,‡,†
  1. 1Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY USA
  2. 2Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  3. 3Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  4. 4Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  5. 5Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  6. 6Mental Illness Research, Education, and Clinical Center (VISN 2 South), James J. Peters VA Medical Center, Bronx, NY, USA
  7. 7Center for Precision Medicine and Translational Therapeutics, James J. Peters VA Medical Center, Bronx, NY, USA
  8. 8VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA
  9. 9Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  10. 10Virus Engineering Center for Therapeutics and Research, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  11. 11Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  12. 12Division of Epidemiology, University of Utah, Salt Lake City, UT, USA
  13. 13Biostatistics Shared Resources, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
  14. 14VA Boston Healthcare System, Boston, MA, USA
  15. 15Division of Aging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  16. 16Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
  17. 17VA Palo Alto Health Care System, Palo Alto, CA, USA
  18. 18Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
  19. 19Department of Genetics and Genome Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
  20. 20VA Northeast Ohio Healthcare System, Cleveland VA Medical Center, Cleveland, OH, USA
  21. 21Department of Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
  22. 22VA Portland Health Care System, Portland, OR, USA
  1. ↵†Corresponding authors: - Georgios Voloudakis (georgios.voloudakis{at}mssm.edu), - Panos Roussos (panagiotis.roussos{at}mssm.edu)

  1. ↵* These authors contributed equally.

Back to top
Posted January 14, 2025.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19
Georgios Voloudakis, Kyung Min Lee, James M. Vicari, Wen Zhang, Daisy Hoagland, Sanan Venkatesh, Jiantao Bian, Marios Anyfantakis, Zhenyi Wu, Samir Rahman, Lina Gao, Kelly Cho, Jennifer S. Lee, Sudha K. Iyengar, Shiuh-Wen Luoh, Themistocles L. Assimes, Gabriel E. Hoffman, Benjamin R. tenOever, John F. Fullard, Julie A. Lynch, Panos Roussos
medRxiv 2025.01.10.25320348; doi: https://doi.org/10.1101/2025.01.10.25320348
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.